Literature DB >> 12650805

Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome.

Thomas J McGarrity1, Laurie P Peiffer, Christopher I Amos, Marsha L Frazier, Margaret G Ward, Mary K Howett.   

Abstract

OBJECTIVE: Peutz-Jeghers syndrome (PJS) is an autosomal-dominant hamartomatous polyposis syndrome. Affected individuals are at risk for intestinal and extraintestinal malignancies. Prostaglandins and polyamines are small molecules believed to be important in tumor formation and growth. Cyclooxygenase (COX) and ornithine decarboxylase (ODC) are key enzymes in the prostaglandin and polyamine biosynthetic pathways, respectively. The aim of this study was to measure and compare COX-1 and COX-2 expression in normal and hamartomatous tissue of PJS patients.
METHODS: We measured COX-1 and COX-2 protein expression in normal and hamartomatous GI tissues from affected PJS individuals and compared it with that in normal controls. COX-2 RNA in these tissues was also measured and compared by reverse transcription polymerase chain reaction (PCR). In addition, COX-2 expression was detected in tissue slides by immunostaining. ODC activity was measured between normal and hamartomatous tissues of PJS compared with control tissues.
RESULTS: COX-1 expression was similar in normal and control GI tissues. In contrast, COX-2 overexpression was noted in hamartomatous polyp tissue from PJS patients compared with normal control and PJS tissue. COX-2 expression by reverse transcription PCR was 10-fold greater in a hamartoma compared with other tissues. COX-2 expression was noted in the epithelial cells of hamartomatous polyps, and also coursing throughout the stromal tissue of the lamina propria, including muscle cells. ODC activity was similar in the tissues studied.
CONCLUSIONS: Selective COX-2 overexpression was noted in hamartomatous polyp tissue from PJS individuals. The results of the study provide an avenue for possible effective chemoprevention of polyp formation and growth in PJS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650805     DOI: 10.1111/j.1572-0241.2003.07328.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  Targeting the LKB1 tumor suppressor.

Authors:  Rui-Xun Zhao; Zhi-Xiang Xu
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 2.  Gastrointestinal polyps and cancer in Peutz-Jeghers syndrome: clinical aspects.

Authors:  A R Latchford; R K S Phillips
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  Cyclooxygenase-2 expression in the hereditary mixed polyposis syndrome.

Authors:  Eli Brazowski; Faina Misonzhnick-Bedny; Paul Rozen
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

4.  Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.

Authors:  Chongjuan Wei; Christopher I Amos; Nianxiang Zhang; Jing Zhu; Xiaopei Wang; Marsha L Frazier
Journal:  Cancer Lett       Date:  2009-01-14       Impact factor: 8.679

5.  Genotype-phenotype correlations in Peutz-Jeghers syndrome.

Authors:  C I Amos; M B Keitheri-Cheteri; M Sabripour; C Wei; T J McGarrity; M F Seldin; L Nations; P M Lynch; H H Fidder; E Friedman; M L Frazier
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

6.  An anti-adenoma antibody, Adnab-9, may reflect the risk for neoplastic progression in familial hamartomatous polyposis syndromes.

Authors:  Martin Tobi; Michael Kam; Nadeem Ullah; Kashif Qureshi; Violeta Yordanova; James Hatfield; Suzanne E G Fligiel; Paula Sochacki; Thomas McGarrity; Carolyn Cole; Michael Lawson; Russell Jacoby
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

7.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

8.  Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas.

Authors:  H Takeda; H Miyoshi; Y Tamai; M Oshima; M M Taketo
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  Peutz-Jeghers Syndrome Manifested as Multiple Polyps in Jejunum With Intussusception.

Authors:  Hai Hua Jiang; Feng Lu; Shu Guang Tan; Sai Qi He
Journal:  J Med Cases       Date:  2022-06-11

Review 10.  Role of LKB1 in lung cancer development.

Authors:  L Makowski; D N Hayes
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.